2024
Sexually Transmitted Infections in People with Human Immunodeficiency Virus
Tuan J, Goheen M, Trebelcock W, Dunne D. Sexually Transmitted Infections in People with Human Immunodeficiency Virus. Infectious Disease Clinics Of North America 2024, 38: 559-579. PMID: 38871569, PMCID: PMC12124183, DOI: 10.1016/j.idc.2024.04.007.Peer-Reviewed Original ResearchConceptsSexually transmitted infectionsHuman immunodeficiency virusImmunodeficiency virusBurden of sexually transmitted infectionsNucleic acid amplification testsSpread of sexually transmitted infectionsTreatment of patientsDiagnosis of syphilisSexual history takingAmplification testsReduce morbidityPostexposure prophylaxisHistory takingScreening practicesMyriad symptomsProvider awarenessPWHPatientsInfectionVirusProphylaxisMorbidityHIVSyphilisDiagnosis
2023
Retrospective evaluation of clinical decision support for within-laboratory optimization of SARS-CoV-2 NAAT workflow
Durant T, Peaper D. Retrospective evaluation of clinical decision support for within-laboratory optimization of SARS-CoV-2 NAAT workflow. Journal Of Clinical Microbiology 2023, 62: e00785-23. PMID: 38132702, PMCID: PMC10865785, DOI: 10.1128/jcm.00785-23.Peer-Reviewed Original ResearchAlgorithms for Detection and Identification of Viruses
Landry M, Babady N, Binnicker M, Pinsky B, Tang Y. Algorithms for Detection and Identification of Viruses. 2023, 1-5. DOI: 10.1002/9781683674849.mcm0084.Peer-Reviewed Original ResearchIntroduction of nucleic acid amplification testingNucleic acid amplification testsRespiratory viral culturesSexually transmitted virusDetection of viral antigensDevelopment of antiviral therapiesImmunosuppressed hostsViral cultureAntiviral therapyRoutine cultureClinical specimensAmplification testsCentrifugation cultureViral antigensEnzyme immunoassayMonoclonal antibodiesDiagnostic virologyIdentification of virusesCapture assayCoronavirus diseaseVirusEmergence of epidemicsMedical careIncreasing numberTherapyAlgorithms for Detection and Identification of Viruses
Landry M, Babady N, Binnicker M, Pinsky B, Tang Y. Algorithms for Detection and Identification of Viruses. 2023, 1-5. DOI: 10.1002/9781683670438.mcm0084.Peer-Reviewed Original ResearchIntroduction of nucleic acid amplification testingNucleic acid amplification testsRespiratory viral culturesSexually transmitted virusDetection of viral antigensDevelopment of antiviral therapiesImmunosuppressed hostsViral cultureAntiviral therapyRoutine cultureClinical specimensAmplification testsCentrifugation cultureViral antigensEnzyme immunoassayMonoclonal antibodiesDiagnostic virologyIdentification of virusesCapture assayCoronavirus diseaseVirusEmergence of epidemicsMedical careIncreasing numberTherapyChoice Architecture to Assist Clinicians with Appropriate COVID-19 Test Ordering
Sangal R, Venkatesh A, Cahill J, Pettker C, Peaper D. Choice Architecture to Assist Clinicians with Appropriate COVID-19 Test Ordering. The Journal Of Applied Laboratory Medicine 2023, 8: 98-105. PMID: 36610419, DOI: 10.1093/jalm/jfac104.Peer-Reviewed Original ResearchConceptsRSV testingSymptomatic visitsED visitsSARS-CoV-2 nucleic acid amplification testsCOVID-19Respiratory syncytial virus testingNucleic acid amplification testsElectronic health record ordersSystems-based interventionsSARS-CoV-2Symptomatic patientsPrimary outcomeInfluenza testingClinical guidelinesClinician educationClinician practiceVirus testingAmplification testsPatientsTest orderingInstitutional guidelinesClinical needHospital systemVisitsTesting patterns
2020
Analysis of National Healthcare Safety Network Clostridioides difficile Infection Standardized Infection Ratio by Test Type
Li Q, Benin A, Guh A, Dudeck M, Allen-Bridson K, Leaptrot D, McDonald L, Pollock D, Edwards J. Analysis of National Healthcare Safety Network Clostridioides difficile Infection Standardized Infection Ratio by Test Type. Infection Control And Hospital Epidemiology 2020, 41: s116-s118. DOI: 10.1017/ice.2020.624.Peer-Reviewed Original ResearchNucleic acid amplification testsStandardized infection ratioEnzyme immunoassaySIR differenceInfection ratioRisk adjustmentCDI incidence ratePositive laboratory testsAcute care hospitalsNHSN dataIncidence rateNAAT useAmplification testsInpatient locationHospital personnelHospitalMost hospitalsCalendar quarterIncident rateNHSNT-testTest combinationsLaboratory testsCDITest typeAnalysis of National Healthcare Safety Network Clostridioides difficile Infection Standardized Infection Ratio by Test Type
Li Q, Benin A, Guh A, Dudeck M, Allen-Bridson K, Leaptrot D, McDonald L, Pollock D, Edwards J. Analysis of National Healthcare Safety Network Clostridioides difficile Infection Standardized Infection Ratio by Test Type. Infection Control And Hospital Epidemiology 2020, 41: s87-s89. DOI: 10.1017/ice.2020.583.Peer-Reviewed Original ResearchNucleic acid amplification testsNational Healthcare Safety NetworkStandardized infection ratioEnzyme immunoassaySIR differenceRisk adjustmentInfection ratioCDI incidence ratePositive laboratory testsAcute care hospitalsNHSN dataIncidence rateAmplification testsNAAT useInpatient locationHospital personnelHospitalMost hospitalsCalendar quarterIncident rateT-testTest combinationsLaboratory testsCDISafety NetworkClinical Validity of Serum Antibodies to SARS-CoV-2
Caturegli G, Materi J, Howard B, Caturegli P. Clinical Validity of Serum Antibodies to SARS-CoV-2. Annals Of Internal Medicine 2020, 173: m20-2889. PMID: 32628534, PMCID: PMC7370852, DOI: 10.7326/m20-2889.Peer-Reviewed Original ResearchConceptsNucleic acid amplification testsJohns Hopkins HospitalAntibodies to SARS-CoV-2SARS-CoV-2Follow-upEpstein-Barr virus capsid antigenSymptom onsetAcute respiratory distress syndromeAssociated with clinical severityRespiratory distress syndromeClinical immunology laboratoryControl groupVirus capsid antigenHealthy laboratory employeesEnzyme-linked immunosorbent assaySARS-CoV-2 IgG assaySARS-CoV-2 spike proteinClinical record reviewThyroperoxidase antibodiesCase patientsDistress syndromeCapsid antigenControl patientsSARS-CoV-2 antibodiesSevere acute respiratory syndrome coronavirus 2Molecular Testing for Acute Respiratory Tract Infections: Clinical and Diagnostic Recommendations From the IDSA’s Diagnostics Committee
Hanson KE, Azar MM, Banerjee R, Chou A, Colgrove RC, Ginocchio CC, Hayden MK, Holodiny M, Jain S, Koo S, Levy J, Timbrook TT, Caliendo AM. Molecular Testing for Acute Respiratory Tract Infections: Clinical and Diagnostic Recommendations From the IDSA’s Diagnostics Committee. Clinical Infectious Diseases 2020, 71: 2744-2751. PMID: 32369578, PMCID: PMC7454374, DOI: 10.1093/cid/ciaa508.Peer-Reviewed Original ResearchConceptsRespiratory tract infectionsAcute respiratory tract infectionsTract infectionsDiagnostics CommitteeSpecific nucleic acid amplification testsBacterial respiratory tract infectionsNucleic acid amplification testsRoutine clinical practiceDiagnostic reference standardNew molecular testsGlobal health responseClinical signsRespiratory medicineAmplification testsClinical practiceMolecular testingClinical judgmentAvailable assaysHealth responseDiagnostic recommendationsNovel coronavirus pandemicMolecular testsReference standardInfectionMolecular diagnosticsOral swab testing by Xpert® MTB/RIF Ultra for mass tuberculosis screening in prisons
Lima F, Santos A, Oliveira R, Silva C, Gonçalves C, Andrews J, Croda J. Oral swab testing by Xpert® MTB/RIF Ultra for mass tuberculosis screening in prisons. Journal Of Clinical Tuberculosis And Other Mycobacterial Diseases 2020, 19: 100148. PMID: 32099908, PMCID: PMC7031315, DOI: 10.1016/j.jctube.2020.100148.Peer-Reviewed Original ResearchNucleic acid amplification testsOral swabsPulmonary tuberculosisSwab testingAmplification testsMTB/RIF UltraMass screening studyOral swab samplingCourse of illnessScreening studySputum cultureXpert testingBacillary loadMycobacterial loadCase findingSputumXpertSwabsTuberculosisFurther studiesSwab samplingParticipantsComparable sensitivityPrison inmatesIndividuals
2018
Detection of Influenza A and B Viruses and Respiratory Syncytial Virus by Use of Clinical Laboratory Improvement Amendments of 1988 (CLIA)-Waived Point-of-Care Assays: a Paradigm Shift to Molecular Tests
Azar MM, Landry ML. Detection of Influenza A and B Viruses and Respiratory Syncytial Virus by Use of Clinical Laboratory Improvement Amendments of 1988 (CLIA)-Waived Point-of-Care Assays: a Paradigm Shift to Molecular Tests. Journal Of Clinical Microbiology 2018, 56: 10.1128/jcm.00367-18. PMID: 29695519, PMCID: PMC6018333, DOI: 10.1128/jcm.00367-18.BooksConceptsRapid influenza diagnostic testsRespiratory syncytial virusNucleic acid amplification testsSyncytial virusB virusInfluenza AClinical Laboratory Improvement AmendmentsAntiviral therapyPoint of careAvailable rapid influenza diagnostic testsSensitive nucleic acid amplification testsMolecular testsInfluenza diagnostic testsRespiratory virus infectionsInfection prevention strategiesRapid antigen detectionRapid laboratory testingViral diagnostic testingDetection of influenzaNew pandemic strainsAccurate laboratory diagnosisRapid antigenRespiratory virusesViral culturePatient management
2016
Laboratory Diagnosis of Zika Virus Infection
Landry ML, St George K. Laboratory Diagnosis of Zika Virus Infection. Archives Of Pathology & Laboratory Medicine 2016, 141: 60-67. PMID: 27763787, DOI: 10.5858/arpa.2016-0406-sa.Peer-Reviewed Original ResearchConceptsNucleic acid amplification testsZika virus infectionZika infectionVirus infectionAmplification testsLaboratory diagnosisNucleic acid amplification testingCommercial nucleic acid amplification testsAccurate antibody testZika virus testingPublic health recommendationsEmergency use authorizationAcute infectionAmplification testingSerology resultsPast infectionFlavivirus antigensHealth recommendationsVirus testingCurrent recommendationsAntibody testApplicable diagnostic toolsVirus epitopesAccurate diagnosisInfection
2014
Modeling of Novel Diagnostic Strategies for Active Tuberculosis – A Systematic Review: Current Practices and Recommendations
Zwerling A, White RG, Vassall A, Cohen T, Dowdy DW, Houben RM. Modeling of Novel Diagnostic Strategies for Active Tuberculosis – A Systematic Review: Current Practices and Recommendations. PLOS ONE 2014, 9: e110558. PMID: 25340701, PMCID: PMC4207742, DOI: 10.1371/journal.pone.0110558.Peer-Reviewed Original ResearchConceptsNucleic acid amplification testsIncremental cost-effectiveness ratioActive tuberculosisHealth system modelDiagnostic strategiesNovel diagnostic strategiesAlternative nucleic acid amplification testsXpert MTB/RIFMTB/RIFCost-effectiveness ratioMulti-way sensitivity analysesFalse-negative diagnosesPre-diagnostic periodCost-effectiveness modelCost-effectiveness estimatesDiagnostic delayDiagnostic pathwayAdditional epidemiological dataTB diagnosticsEpidemiological dataReference listsAmplification testsEpidemiological impactEligible papersEpidemiological settingsDeterminants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations
Lessa F, Mu Y, Winston L, Dumyati G, Farley M, Beldavs Z, Kast K, Holzbauer S, Meek J, Cohen J, McDonald L, Fridkin S. Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations. Open Forum Infectious Diseases 2014, 1: ofu048. PMID: 25734120, PMCID: PMC4281776, DOI: 10.1093/ofid/ofu048.Peer-Reviewed Original ResearchNucleic acid amplification testsClostridium difficile infectionCDI incidenceHA-CDICA-CDIOlder ageClostridium difficile infection (CDI) incidenceDay of admission
2010
Sexual abuse and sexually transmitted infections in children and adolescents
Bechtel K. Sexual abuse and sexually transmitted infections in children and adolescents. Current Opinion In Pediatrics 2010, 22: 94-99. PMID: 19952927, DOI: 10.1097/mop.0b013e32833502ad.Peer-Reviewed Original ResearchConceptsNucleic acid amplification testsHIV postexposure prophylaxisHuman papillomavirusPostexposure prophylaxisPrepubertal childrenChlamydia trachomatisNeisseria gonorrhoeaeTransmission of HIVMode of transmissionSexual abuseAnogenital infectionOutpatient supportSpecific infectionsSuch infectionsHigh riskSimplex virusAmplification testsC. trachomatisN. gonorrhoeaeInfectionChild protective servicesTrachomatisGonorrhoeaeProphylaxisHIV
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply